Regardless of whether a tumor is IDH-mutant or IDH-wild type, PKM2 expression remains consistent, indicating that PKM2 may not be directly influenced by the IDH mutation in the context of GBM and ASTROG4. The gene discussed is IDH1; the disease is neoplasm.